title: [Increased thrombolysis and decreased platelet aggregation with an anti-GPIIb/IIIa antibody urokinase hybrid molecule (7E3-UK)].
authors.affiliation: Medizinische Klinik III-Kardiologie, Universität Heidelberg.
authors.forename: C
authors.initials: C
authors.lastname: Bode
authors.forename: T
authors.initials: T
authors.lastname: Nordt
authors.forename: M
authors.initials: M
authors.lastname: Freitag
authors.forename: J
authors.initials: J
authors.lastname: Ruef
authors.forename: M
authors.initials: M
authors.lastname: Kaltenmeier
authors.forename: G
authors.initials: G
authors.lastname: Meinhardt
authors.forename: W
authors.initials: W
authors.lastname: Kübler
authors.forename: E
authors.initials: E
authors.lastname: Haber
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D005341:Fibrinolysin / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D010958:Plasminogen / Q000378:metabolism; D010980:Platelet Membrane Glycoproteins / Q000276:immunology*; D015912:Thrombolytic Therapy / Q000379:methods*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D010980:Platelet Membrane Glycoproteins; D010958:Plasminogen; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator
vernacular_title: Verstärkte Thrombolyse und verminderte Thrombozytenaggregation durch ein anti-GPIIb/IIIa-Antikörper Urokinase Hybridmolekül (7E3-UK).